{"id":229,"date":"2015-02-03T17:00:23","date_gmt":"2015-02-03T22:00:23","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=229"},"modified":"2015-02-03T17:00:23","modified_gmt":"2015-02-03T22:00:23","slug":"secondarys-announced-2-3-2015","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondarys-announced-2-3-2015\/","title":{"rendered":"Secondary’s Announced 2.3.2015"},"content":{"rendered":"

IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record<\/a> for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. To subscribe to his secondary ratings, click here. <\/a><\/p>\n

Company: ServiceMaster Global Holdings, Inc.<\/strong>
\nSymbol: SERV
\nPrice: Last trade $28.20
\nTrade Date: 2\/6
\nShares: 25 million
\nUnderwriter(s) J.P. Morgan, Credit Suisse, Morgan Stanley, Goldman Sachs
\nCo Manager(s) BofA Merrill Lynch, Jefferies, Natixis, RBC Capital Markets, Baird, Piper Jaffray, Ramirez
\nRating=Subscription Needed<\/a><\/p>\n

Company: Omega Healthcare<\/strong>
\nSymbol: OHI
\nPrice: Last trade $43.61
\nTrade Date: 2\/4
\nShares: 8 million
\nUnderwriter(s) BofA Merrill Lynch, J.P. Morgan, Morgan Stanley, Stifel
\nRating=Subscription Needed<\/a><\/p>\n

Company: Tonix Pharmaceuticals<\/strong>
\nSymbol: TNXP
\nPrice: Last trade $6.06
\nTrade Date: 2\/4
\nShares: 4.1 million
\nUnderwriter(s) Roth Capital Partners, Oppenheimer & Co.
\nCo Manager(s) Janney Montgomery Scott
\nRating=Subscription Needed<\/a><\/p>\n

Company: Intercept Pharmaceuticals, Inc.<\/strong>
\nSymbol: ICPT
\nPrice: Last trade $189.07
\nTrade Date: 2\/5
\nShares: 800,000
\nUnderwriter(s) Citigroup, RBC Capital Markets
\nRating=Subscription Needed<\/a><\/p>\n

Company: Senior Housing Properties Trust<\/strong>
\nSymbol: SNH
\nPrice: Last trade $23.30
\nTrade Date: 2\/4
\nShares: 25 million
\nUnderwriter(s) Citigroup, BofA Merrill Lynch, Morgan Stanley, Jefferies, RBC Capital Markets
\nRating=Subscription Needed<\/a><\/p>\n

Company: Catalyst Pharmaceutical Partners Inc.<\/strong>
\nSymbol: CPRX
\nPrice: Last trade $3.52
\nTrade Date: 2\/4
\nShares: 8.5 million
\nUnderwriter(s) Piper Jaffray
\nRating=Subscription Needed<\/a><\/p>\n

Company: Ultragenyx Pharmaceutical Inc.<\/strong>
\nSymbol: RARE
\nPrice: Last trade $57.58
\nTrade Date: 2\/5
\nShares: 2.2 million
\nUnderwriter(s) Morgan Stanley, Cowen, Jefferies
\nCo Manager(s) Baird, Canaccord Genuity, JMP Securities, SunTrust Robinson Humphrey, Wedbush PacGrow Life Sciences
\nRating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. To subscribe to his secondary ratings, click here. Company: ServiceMaster Global Holdings, Inc.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[97,95,93,15,92,96,94],"class_list":["post-229","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-cprx","tag-icpt","tag-ohi","tag-rare","tag-serv","tag-snh","tag-tnxp"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/229","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=229"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/229\/revisions"}],"predecessor-version":[{"id":230,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/229\/revisions\/230"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=229"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=229"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=229"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}